Venture Life Group PLC Investor evening
20 December 2016 - 6:00PM
RNS Non-Regulatory
TIDMVLG
Venture Life Group PLC
20 December 2016
20 December 2016
Venture Life Group plc
("Venture Life", the "Company" or the "Group")
Investor evening
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the ageing population, announces that it will be
hosting a presentation for investors on the afternoon of Thursday
26 January 2017.
Jerry Randall, CEO will provide an overview of the Company and
where it is currently positioned. The afternoon will also feature
presentations by:
-- Mr Vincent Poujardieu, Vice President of Rasio Group plc and
General Manager of the Benecol Division. Vincent will be speaking
about Benecol and the benefits the brand offers as a functional
food and a food supplement.
-- Mr Gianluca Braguti, founder of Biokosmes and Development and
Manufacturing Director at Venture Life. Gianluca will be speaking
about the new products developed at Biokosmes, including new
Benecol products, to be launched in 2017 by Venture Life.
-- Dr Mervyn Druian, Aesthetic Dentist. Mervyn originally
brought the UltraDEX product to the UK more than 20 years ago. He
has successfully used UltraDEX long term in his clinic in Primrose
Hill, and will be speaking about the benefits of UltraDEX for his
patients and the advantages it offers over the competition.
-- Mr Tim Scott, UK Sales Director, Venture Life. Tim has
recently joined Venture Life and has extensive experience in the UK
retail pharmacy space. Tim will talk about the UK market trends in
both the pharmacy and grocery sector and also about the commercial
opportunity for UltraDEX in the UK.
The presentation will be held at the offices of Panmure Gordon,
One New Change, London EC4M 9AF. The event will begin at 3pm, and
after brief presentations, drinks and canapes will be served to
allow guests to talk further with the speakers.
Space is limited so please register your interest, please
contact venturelife@walbrookpr.com or call 020 7933 8780.
No new material or trading information will be provided.
For further information please contact:
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive
Officer
Panmure Gordon (UK) Limited (Nominated +44 (0) 20 7886
Adviser and Joint Broker) 2500
Freddy Crossley/Peter Steel/Duncan
Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Ltd +44 (0) 20 3621
(Joint Broker) 4120
James Pope/Ben Turner
Walbrook PR venturelife@walbrookpr.com
or +44 (0) 20 7933 8780
Paul McManus/Anna Dunphy +44 (0) 7980 541 893 / +44
(0) 7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFERFSLALIR
(END) Dow Jones Newswires
December 20, 2016 02:00 ET (07:00 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2024 to May 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From May 2023 to May 2024